JP2017533215A5 - - Google Patents

Download PDF

Info

Publication number
JP2017533215A5
JP2017533215A5 JP2017523293A JP2017523293A JP2017533215A5 JP 2017533215 A5 JP2017533215 A5 JP 2017533215A5 JP 2017523293 A JP2017523293 A JP 2017523293A JP 2017523293 A JP2017523293 A JP 2017523293A JP 2017533215 A5 JP2017533215 A5 JP 2017533215A5
Authority
JP
Japan
Prior art keywords
methyl
pyrido
pyrimidin
amino
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017523293A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017533215A (ja
JP6505222B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2015/011386 external-priority patent/WO2016068580A2/en
Publication of JP2017533215A publication Critical patent/JP2017533215A/ja
Publication of JP2017533215A5 publication Critical patent/JP2017533215A5/ja
Application granted granted Critical
Publication of JP6505222B2 publication Critical patent/JP6505222B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017523293A 2014-10-29 2015-10-27 ヒストンリジン脱メチル化触媒活性を調節するための新規ピリドピリミジノン化合物 Expired - Fee Related JP6505222B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462069915P 2014-10-29 2014-10-29
US62/069,915 2014-10-29
PCT/KR2015/011386 WO2016068580A2 (en) 2014-10-29 2015-10-27 Novel pyridopyrimidinone compounds for modulating the catalytic activity of histone lysine demethylases (kdms)

Publications (3)

Publication Number Publication Date
JP2017533215A JP2017533215A (ja) 2017-11-09
JP2017533215A5 true JP2017533215A5 (enExample) 2018-11-01
JP6505222B2 JP6505222B2 (ja) 2019-04-24

Family

ID=55851908

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017523293A Expired - Fee Related JP6505222B2 (ja) 2014-10-29 2015-10-27 ヒストンリジン脱メチル化触媒活性を調節するための新規ピリドピリミジノン化合物

Country Status (13)

Country Link
US (1) US9834550B2 (enExample)
EP (1) EP3212647B1 (enExample)
JP (1) JP6505222B2 (enExample)
KR (1) KR101978899B1 (enExample)
CN (1) CN107001358A (enExample)
AU (1) AU2015340215B2 (enExample)
BR (1) BR112017008312A2 (enExample)
CA (1) CA2962917C (enExample)
MX (1) MX2017005346A (enExample)
NZ (1) NZ730475A (enExample)
RU (1) RU2684396C2 (enExample)
SG (1) SG11201702075QA (enExample)
WO (1) WO2016068580A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6853819B2 (ja) * 2015-10-08 2021-03-31 スーチョウ ユンシュアン イーヤオ カジ ヨウシェン ゴンス Wntシグナル伝達経路阻害剤およびその治療用途
US10221191B2 (en) 2015-12-22 2019-03-05 SHY Therapeutics LLC Compounds for the treatment of cancer and inflammatory disease
SG11201911929XA (en) 2017-06-21 2020-01-30 SHY Therapeutics LLC Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
WO2020011086A1 (zh) * 2018-07-13 2020-01-16 四川科伦博泰生物医药股份有限公司 苯并二氮杂环类化合物、其制备方法及用途
WO2020132071A1 (en) 2018-12-19 2020-06-25 Shy Therapeutics. Llc Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and f1brotic disease
EP4098650B1 (en) 2020-01-31 2025-12-10 Kumiai Chemical Industry Co., Ltd. 3-alkoxy benzoic acid amide derivative, and pest control agent
EP4126847A1 (en) 2020-03-30 2023-02-08 ENYO Pharma Quinazolinone derivatives and uses thereof for treating a cancer
WO2021198191A1 (en) 2020-03-30 2021-10-07 Enyo Pharma Quinazolinone derivatives and uses thereof for treating a cancer
JP7768592B2 (ja) * 2021-03-31 2025-11-12 デューク ストリート バイオ リミテッド 医薬化合物
GB202114315D0 (en) * 2021-10-06 2021-11-17 Duke Street Bio Ltd Pharmaceutical compound

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939421A (en) * 1997-07-01 1999-08-17 Signal Pharmaceuticals, Inc. Quinazoline analogs and related compounds and methods for treating inflammatory conditions
GB9909135D0 (en) * 1999-04-22 1999-06-16 Univ Wales Medicine Cystic fibrosis medicaments
WO2003045911A1 (en) * 2001-11-26 2003-06-05 Dsm Ip Assets B.V. Process for recovering caprolactam
FR2846657B1 (fr) 2002-11-05 2004-12-24 Servier Lab Nouveaux composes pyridopyrimidinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2005032481A2 (en) * 2003-09-30 2005-04-14 Scios Inc. Quinazoline derivatives as medicaments
NZ546477A (en) 2006-04-07 2009-04-30 Auckland Uniservices Ltd 4-Alkylamino-2-(heterocyclic)quinazolines and their use in cancer therapy
EP2734520B1 (en) * 2011-07-19 2016-09-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
AU2013323360B2 (en) * 2012-09-28 2017-09-07 Cancer Research Technology Limited Azaquinazoline inhibitors of atypical protein kinase C
US20150272939A1 (en) 2012-10-02 2015-10-01 Yale University Identification of Small Molecule Inhibitors of Jumonji AT-Rich Interactive Domain 1A (JARID1A) and 1B (JARID1B) Histone Demethylase
HRP20170358T1 (hr) 2012-10-02 2017-04-21 Gilead Sciences, Inc. Inhibitori histonskih demetilaza
WO2014087165A1 (en) * 2012-12-06 2014-06-12 University Of Bath Tankyrase inhibitors
ES2670864T3 (es) 2013-02-27 2018-06-01 Gilead Sciences, Inc. Inhibidores de histonas desmetilasas
WO2014164708A1 (en) 2013-03-12 2014-10-09 Quanticel Pharmaceuticals, Inc. Histone dementhylase inhibitors
EP2970307B1 (en) 2013-03-13 2020-03-11 Genentech, Inc. Pyrazolo compounds and uses thereof
PL2970211T3 (pl) 2013-03-15 2018-01-31 Quanticel Pharmaceuticals Inc Inhibitory demetylazy histonowej
EP3041474B1 (en) 2013-09-05 2020-03-18 Genentech, Inc. Antiproliferative compounds
CN103694255A (zh) * 2014-01-09 2014-04-02 华中师范大学 吡啶并噁嗪酮和吡啶并嘧啶酮类化合物及其制备方法与应用
TWI675836B (zh) * 2014-03-25 2019-11-01 美商伊格尼塔公司 非典型蛋白質激酶c之氮雜喹唑啉抑制劑

Similar Documents

Publication Publication Date Title
JP2017533215A5 (enExample)
JP6349360B2 (ja) Cb2アゴニストとして有用なピリジン−2−アミド
DE60028740T2 (de) Phthalazinderivate zur behandlung von entzündlichen erkrankungen
KR101078505B1 (ko) 질소 함유 복소환 유도체 및 이들을 유효 성분으로 하는약제
JP5818901B2 (ja) 疼痛、精神病性障害、認知障害、またはアルツハイマー病の治療のためのアルファ‐7ニコチン性受容体修飾薬
RU2017113007A (ru) Новые соединения пиридопиримидинона для модулирования каталитической активности гистонлизиндеметилаз (KDMS)
TWI400232B (zh) 含氮雜環衍生物及以該含氮雜環衍生物為有效成分之藥劑
US20120157433A1 (en) Heteroaryl Compounds as Kinase Inhibitors
JP2012529535A (ja) キナーゼモジュレーターとして有用なニコチンアミド化合物
JP2017522346A (ja) ブロモドメインに対して活性な化合物
US20110166132A1 (en) Gamma Secretase Modulators
EP3651762B1 (en) Antagonists of the muscarinic acetylcholine receptor m4
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
KR20040048920A (ko) 글리코겐 신타아제 키나제 3-베타 저해제(gsk저해제)로서의 헤테로아릴 아민
JP2014506878A (ja) Cdk9阻害剤としての置換ビ−ヘテロアリール化合物およびそれらの使用
JP2005506350A (ja) サイトカイン阻害薬としての1,4−二置換ベンゾ−縮合尿素化合物
CA2634676A1 (en) Trisubstituted amine compounds as inhibitors of cholesteryl ester transfer protein cetp
JP2011522865A (ja) Ia心不全および癌の治療に有用なプロテインキナーゼd阻害剤としての2,4’−ビピリジニル化合物
JP2012529435A (ja) アルカノイルアミノベンズアミドアニリンhdacインヒビター化合物
US20120165306A1 (en) Pyrazinylpyridines useful for the treatment of proliferative diseases
JP2004531571A (ja) サイトカイン生産のインヒビターとしてのカルバメート及びオキサミド化合物
UA122065C2 (uk) 5-[(піперазин-1-іл)-3-оксопропіл]-імідазолідин-2,4-діонові похідні як інгібітори adamts для лікування остеоартриту
KR20160079907A (ko) 염증 질환의 치료에 사용되기 위한 화합물, 의약 조성물 및 방법
KR101830566B1 (ko) 테트라히드로이소퀴놀린-1-온 유도체 또는 그의 염
TW200413385A (en) Condensed furan compounds